Gritstone Oncology picks up $92.7 mln
San Francisco Bay area-based Gritstone Oncology, a cancer immunotherapy company, has closed $92.7 million in financing. Lilly Asia Ventures led the round with participation from other investors that included GV, Trinitas Capital, Alexandria Venture Investments, Versant Ventures, The Column Group, Clarus Funds and Frazier Healthcare Partners. Cowen served as financial adviser to Gritstone on the transaction.
7 September 2017•1 min read
